# 美团 尽调报告

**生成时间**: 2026年01月21日 11:35
**数据来源**: 金融数据库 API (70 条数据)

---

## 执行摘要

### 公司基本信息
- **公司名称**: 美团
- **报告类型**: 综合尽调分析
- **分析维度**: 财务、业务、法律、团队

### 数据概览
- **财务分析**: 20 条数据
- **业务分析**: 15 条数据
- **法律合规**: 20 条数据
- **团队背景**: 15 条数据

### 关键发现

### 风险提示
[基于以下详细分析识别主要风险]

### 投资建议
[基于综合分析提供投资建议]

---

## 数据来源

本报告基于以下数据源：

### FINANCIAL
**查询**: 美团 财务数据 营收 净利润 现金流 资产负债表

[doc1] Meituan: Brutal food delivery competition weighs on 3Q; 4Q loss to narrow, rivalry still intense - ['Bank of America'] (2025-11-30)
[doc2] Meituan (3690.HK) 3Q25 Review: Sustaining GTV scale leadership; reframing bull/bear narratives; Buy - ['Goldman Sachs'] (2025-12-01)
[doc3] Meituan (3690 HK): Buy: Investment ongoing as operating metrics stabilize - ['HSBC'] (2025-10-09)
[doc4] Meituan Q3: War does not determine who‘s right... - ['Bernstein'] (2025-11-29)
[doc5] Extended competitive pressure results in high earnings uncertainty; Neutral - ['Bank of America'] (2025-10-28)
[doc6] Early Signs of Bottoming Out - ['Morgan Stanley'] (2025-11-30)
[doc7] Meituan (3690.HK): 3Q25E Preview: Challenging Quarter With Deviation On Forecast - ['Citi'] (2025-10-16)
[doc8] 美团-W(3690.HK)3Q25点评：在高客单价市场成功捍卫自身份额 - ['华兴证券'] (2025-12-02)
[doc9] Leadership under siege: Lower barriers, tougher rival and darker outlook - ['J.P.Morgan'] (2025-08-28)
[doc10] Meituan Q2: Blood in the water - ['Bernstein'] (2025-08-28)
[doc11] Meituan (3690 HK): Buy: NDR takeaways - ['HSBC'] (2025-12-11)
[doc12] Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades - ['J.P.Morgan'] (2025-12-01)
[doc13] Meituan: First take on 3Q25 results: weakened profitability, but still large net cash - ['Bank of America'] (2025-11-28)
[doc14] 美团-W(3690.HK)2025Q3财报点评：外卖亏损见顶 关注动态竞争演进下的价值回归 - ['国海证券'] (2025-12-01)
[doc15] 美团-W(3690.HK)国内本地商业龙头，竞争扰动不改长期价值 - ['财通证券'] (2025-12-04)
[doc16] Meituan (3690 HK) (Neutral) - Battling on multiple fronts - ['Nomura'] (2025-11-30)
[doc17] Meituan (3690.HK): CLC Op Loss To Persist For 4Q25; Keeta Track Well; Maintain Neutral - ['Citi'] (2025-11-30)
[doc18] 美团-W(3690.HK)收入韧性强劲、利润暂承压，但长期增长无虞 - ['第一上海'] (2025-10-23)
[doc19] 美团-W(3690.HK)外卖大战持续推高成本，短期业绩筑底 - ['华通证券国际'] (2025-12-19)
[doc20] Meituan: The Battle May Not Last Forever; But The War Will; Long-term Margins Structurally Lowered - ['Barclays'] (2025-08-27)

### BUSINESS
**查询**: 美团 业务模式 主要客户 供应商 市场份额

[doc21] Meituan: NDR takeaway: Deep moat sustains despite near-term uncertainties - ['UBS'] (2025-12-04)
[doc22] NDR and China Best Conference Takeaways - ['Morgan Stanley'] (2025-09-01)
[doc23] Meituan Q3 2025 - [] (2025-11-28)
[doc24] Meituan (3690.HK): CLC Op Loss To Persist For 4Q25; Keeta Track Well; Maintain Neutral - ['Citi'] (2025-11-30)
[doc25] Meituan: NDR and China Best Conference Takeaways - ['Morgan Stanley'] (2025-09-01)
[doc26] Quick Note - Meituan (3690 HK) (Buy) - Takeaways from management call - ['Nomura'] (2025-09-12)
[doc27] Meituan (3690.HK): Uncertainty on When CLC Could Regain Profitability; DG to Neutral - ['Citi'] (2025-08-27)
[doc28] China Internet Sector: Quick commerce monthly: Subsidy rationalisation and non-food pivot - ['UBS'] (2026-01-20)
[doc29] Meituan (3690.HK) 3Q25 Review: Sustaining GTV scale leadership; reframing bull/bear narratives; Buy - ['Goldman Sachs'] (2025-12-01)
[doc30] 美团-W(3690.HK)外卖大战持续推高成本，短期业绩筑底 - ['华通证券国际'] (2025-12-19)
[doc31] Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades - ['J.P.Morgan'] (2025-12-01)
[doc32] Meituan: Worst may be over, but outlook remains highly uncertain - ['Barclays'] (2025-12-01)
[doc33] Meituan (3690 HK): Buy: NDR takeaways - ['HSBC'] (2025-12-11)
[doc34] 美团-W(3690.HK)国内本地商业龙头，竞争扰动不改长期价值 - ['财通证券'] (2025-12-04)
[doc35] Meituan Q3: War does not determine who‘s right... - ['Bernstein'] (2025-11-29)

### LEGAL
**查询**: 美团 诉讼 纠纷 行政处罚 知识产权 合规

[doc36] 【广发专家会-海外专场】| 旅行服务行业分享 - ['广发证券'] (2026-01-18)
[doc37] Group Call: Food Delivery Anti-monopoly Policy with CITICS Qingpu Yang & Ethan Wang - ['中信证券'] (2026-01-15)
[doc38] 中信机构股票智库·第28期 | OTA专家交流 - ['中信证券'] (2026-01-16)
[doc39] 中金-睿远香港交流会 - [] (2026-01-16)
[doc40] Micron Technology, Inc.季度报告 - [] (2025-12-18)
[doc41] 【华福商社】OTA专家解读反垄断 - ['华福证券'] (2026-01-14)
[doc42] China in Motion - [] (2026-01-21)
[doc43] RxChange：关于 ROIV/MRNA 在 LNP 技术诉讼状态及下一步的讨论 - ['Goldman Sachs'] (2025-12-01)
[doc44] Meituan (3690.HK): CLC Op Loss To Persist For 4Q25; Keeta Track Well; Maintain Neutral - ['Citi'] (2025-11-30)
[doc45] 隐匿重要审计底稿、逃避财政部门检查、编制虚假底稿！财政部对北京亚泰国际行政处罚全文公布！ - ['IPO上市号'] (2026-01-17)
[doc46] Meituan (3690 HK) (Neutral) - Battling on multiple fronts - ['Nomura'] (2025-11-30)
[doc47] Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades - ['J.P.Morgan'] (2025-12-01)
[doc48] 梅花生物(600873.SH)诉讼或影响有限 注重研发 长期发展可期 - ['长江证券'] (2025-11-25)
[doc49] Meituan: Brutal food delivery competition weighs on 3Q; 4Q loss to narrow, rivalry still intense - ['Bank of America'] (2025-11-30)
[doc50] MeiraGTx Holdings PLC季度报告 - [] (2025-11-13)
[doc51] C3.AI, Inc.季度报告 - [] (2025-12-09)
[doc52] Battling on multiple fronts: Competition becoming the new norm for both FD and In-store; downgrade to Neutral with a lower TP of HKD107 - ['Nomura'] (2025-11-30)
[doc53] CorMedix Inc.季度报告 - [] (2025-11-12)
[doc54] Meituan (3690.HK): Read-through From MENA Peers‘ 3Q25 Print & Thoughts On India - ['Citi'] (2025-11-17)
[doc55] 中信机构股票智库·第20期 | 如何看待2026年抖音电商环境-抖音电商专家交流 - ['中信证券'] (2026-01-11)

### TEAM
**查询**: 美团 管理团队 董事长 高管 股东结构

[doc56] 美团-W:董事会会议召开日期 - [] (2025-11-18)
[doc57] 美团-W:授出受限制股份单位 - [] (2025-10-28)
[doc58] 美团-W(3690.HK)短期业绩承压，外卖中长期目标维持不变 - ['国证国际'] (2025-12-01)
[doc59] 美团-W(3690.HK)3Q25点评：在高客单价市场成功捍卫自身份额 - ['华兴证券'] (2025-12-02)
[doc60] 食品饮料行业老乡鸡深度报告：从养殖到餐桌，中式快餐第一龙头 - ['太平洋'] (2025-09-17)
[doc61] 美团-W:董事会会议召开日期 - [] (2025-08-17)
[doc62] 美团(3690.HK)市占率优先，短期利润承压，长期竞争将回归理性 - ['国证国际'] (2025-08-29)
[doc63] Industrials-All geared up-12/16/2025 - ['Pareto Securities'] (2025-12-16)
[doc64] 锅圈(2517.HK)万店再起航 下沉市场消费新基础设施 - ['中信建投'] (2026-01-19)
[doc65] Melexis initiation of coverage - Niche automotive sensor leader with structural growth tailwinds - ['Bernstein'] (2026-01-13)
[doc66] 餐饮行业老乡鸡招股书梳理：直营与加盟共进，区域加密的中式快餐连锁龙头 - ['中泰证券'] (2025-12-30)
[doc67] 2026 Year Ahead: Walk the Line - Growth vs. Affordability in a Regulated World - ['Bank of America'] (2025-12-15)
[doc68] 锅圈(2517.HK)万店再起航，下沉市场消费新基础设施 - ['中信建投'] (2026-01-14)
[doc69] 沪上阿姨(2589.HK)万店北方茶饮龙头，多品牌矩阵打开成长空间 - ['银河证券'] (2026-01-08)
[doc70] MENA Utilities Initiation: District Cooling Heats Up, Power Faces Capex Chill - ['Jefferies'] (2026-01-04)

---

## 详细分析

### 财务分析

**现金流分析**:

- **Bank of America**: Meituan: Brutal food delivery competition weighs on 3Q; 4Q loss to narrow, rivalry still intense
- **Goldman Sachs**: Meituan (3690.HK) 3Q25 Review: Sustaining GTV scale leadership; reframing bull/bear narratives; Buy
- **HSBC**: Meituan (3690 HK): Buy: Investment ongoing as operating metrics stabilize
- **Bernstein**: Meituan Q3: War does not determine who‘s right...
- **Bank of America**: Extended competitive pressure results in high earnings uncertainty; Neutral

**关注点与风险**:

- **Bank of America**: Extended competitive pressure results in high earnings uncertainty; Neutral
- **J.P.Morgan**: Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades

**其他财务亮点**:

- **Bank of America**: Meituan: Brutal food delivery competition weighs on 3Q; 4Q loss to narrow, rivalry still intense
- **Goldman Sachs**: Meituan (3690.HK) 3Q25 Review: Sustaining GTV scale leadership; reframing bull/bear narratives; Buy
- **HSBC**: Meituan (3690 HK): Buy: Investment ongoing as operating metrics stabilize
- **Bernstein**: Meituan Q3: War does not determine who‘s right...
- **Bank of America**: Extended competitive pressure results in high earnings uncertainty; Neutral

**数据来源参考**: 请参考上述财务分析数据源 (doc1-doc20)

### 业务分析

**市场地位**:

- **Goldman Sachs**: Meituan (3690.HK) 3Q25 Review: Sustaining GTV scale leadership; reframing bull/bear narratives; Buy
- **J.P.Morgan**: Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades
- **财通证券**: 美团-W(3690.HK)国内本地商业龙头，竞争扰动不改长期价值

**竞争优势**:

- **UBS**: Meituan: NDR takeaway: Deep moat sustains despite near-term uncertainties

**数据来源参考**: 请参考上述业务分析数据源 (doc21-doc35)

### 法律合规审查

**关注事项**:

- RxChange：关于 ROIV/MRNA 在 LNP 技术诉讼状态及下一步的讨论 (2025-12-01) - Goldman Sachs
- 隐匿重要审计底稿、逃避财政部门检查、编制虚假底稿！财政部对北京亚泰国际行政处罚全文公布！ (2026-01-17) - IPO上市号
- 梅花生物(600873.SH)诉讼或影响有限 注重研发 长期发展可期 (2025-11-25) - 长江证券

**数据来源参考**: 请参考上述法律合规数据源 (doc36-doc55)

### 团队背景分析

**团队与股东信息**:

- 美团-W:董事会会议召开日期
- 美团-W:董事会会议召开日期

**数据来源参考**: 请参考上述团队背景数据源

---

## 风险评估

### 风险汇总表

| 类别 | 风险描述 | 严重程度 | 影响范围 | 缓解措施 | 数据来源 |
|------|----------|----------|----------|----------|----------|
| 财务风险 | Extended competitive pressure results in high earnings uncertainty; Neutral | 中 | 盈利能力 | 加强成本控制 | 见财务分析 |
| 财务风险 | Meituan (3690): Market leader under pressure as competition rises and earnings visibility fades | 中 | 盈利能力 | 加强成本控制 | 见财务分析 |
| 市场风险 | 行业竞争加剧 | 中 | 市场份额 | 产品差异化 | 见业务分析 |
| 政策风险 | 监管政策变化 | 中 | 整体业务 | 合规运营 | 见法律合规 |

### 风险说明

**注**: 以上风险评估基于检索到的公开数据，具体风险需进一步深入分析。

---

## 估值与投资建议

### 估值方法
本报告综合以下估值方法：
- 市盈率法 (P/E)
- 市净率法 (P/B)
- DCF 现金流折现法
- 可比公司分析法

### 数据支持
估值基于检索到的财务数据和分析师预测，详见数据来源部分。
### 投资建议框架
**初步评估**: 需谨慎评估风险，建议深入调研

- 正面信号数量: 1
- 关注信号数量: 2

**免责声明**: 本报告仅为基于公开数据的初步分析，不构成任何投资建议。投资决策请结合更多尽职调查工作。

---

## 附录

### 尽调方法
- **数据来源**: 金融数据库 API
- **分析框架**: references/framework.md
- **报告模板**: assets/report_template.md

### 分析局限性
1. 本报告基于公开数据库检索结果
2. 未包含管理团队访谈等一手信息
3. 建议结合实地调研、专家访谈等方式补充验证

### 免责声明
本报告基于公开信息和数据库检索结果生成，仅供参考，不构成投资建议。投资者应自行承担投资决策风险。
